Advances in tuberculous meningitis diagnosis.

Area of Science:

• Neurology
• Infectious Diseases
• Microbiology

Background:

• Tuberculous meningitis (TBM) is the most severe form of tuberculosis, leading to high mortality and irreversible neurological damage.
• Diagnosis is difficult due to vague symptoms and low bacterial load, making conventional methods often insufficient.
• Early detection and treatment are critical for improving outcomes in TBM cases.

Purpose of the Study:

• To review the current laboratory methods for diagnosing TBM.
• To assess the limitations and adequacy of existing diagnostic approaches.
• To highlight the need for improved diagnostic tools.

Main Methods:

• Literature review of existing diagnostic methods for TBM.
• Analysis of the sensitivity and specificity of conventional and molecular tests.
• Evaluation of the utility of cerebrospinal fluid (CSF) Interferon-Gamma Release Assays (IGRAs).

Main Results:

• Conventional microscopy and culture methods show limited sensitivity for TBM diagnosis.
• Rapid molecular tests like real-time PCR and Xpert Ultra show promise but require optimization for TBM.
• CSF IGRA cannot distinguish between active and latent TB infections.

Conclusions:

• No single current laboratory test provides adequate accuracy for diagnosing TBM.
• There is an urgent need for the development of a reliable point-of-care diagnostic test for TBM.
• Improved diagnostic strategies are essential for timely intervention and better patient outcomes.